导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -10.59% | 141/243 |
| 近一周 | -2.86% | 110/249 |
| 近一月 | -6.27% | 156/249 |
| 近一季 | -6.95% | 159/249 |
| 近半年 | -2.16% | 127/245 |
| 近一年 | -12.26% | 117/238 |
| 近两年 | 7.90% | 180/207 |
| 近三年 | 18.17% | 99/165 |
| 成立以来 | 179.20% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.70% 264/360 |
5.46% 163/366 |
- - |
- - |
| 2025 | 4.18% 296/358 |
-11.51% 316/340 |
9.83% 149/348 |
8.95% 158/354 |
-1.62% 187/358 |
| 2024 | 23.63% 60/329 |
2.88% 144/280 |
-0.41% 205/310 |
6.95% 135/318 |
12.83% 1/329 |
| 2023 | 38.48% 43/275 |
13.31% 48/205 |
18.63% 29/230 |
-5.93% 175/262 |
9.51% 96/276 |
| 2022 | -29.22% 138/201 |
-9.26% 79/153 |
-20.31% 143/164 |
9.36% 7/189 |
-10.50% 188/202 |
| 2021 | 22.22% 38/150 |
4.62% 75/312 |
3.98% 152/328 |
0.98% 52/358 |
11.27% 17/151 |
| 2020 | 18.09% 29/103 |
-20.73% 218/280 |
28.57% 49/295 |
9.82% 51/299 |
5.51% 196/305 |
| 2019 | 27.31% 29/88 |
12.20% 83/258 |
6.80% 11/268 |
4.01% 39/253 |
2.14% 185/266 |
| 2018 | 5.47% 2/79 |
- - |
- - |
- - |
-14.43% 163/241 |
| 2017 | 12.90% 42/69 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 华宝标普美国消费人民币A VS. 建信富时100指数(QDII)人民币A(539003) |